Works by Simon, Iris


Results: 21
    1

    TGF-β An emerging player in drug resistance.

    Published in:
    Cell Cycle, 2013, v. 12, n. 18, p. 2960, doi. 10.4161/cc.26034
    By:
    • Brunen, Diede;
    • Willems, Stefan M.;
    • Kellner, Udo;
    • Midgley, Rachel;
    • Simon, Iris;
    • Bernards, René
    Publication type:
    Article
    2

    BRCA1-like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potential.

    Published in:
    Molecular Oncology, 2015, v. 9, n. 8, p. 1528, doi. 10.1016/j.molonc.2015.04.011
    By:
    • Severson, Tesa M.;
    • Peeters, Justine;
    • Majewski, Ian;
    • Michaut, Magali;
    • Bosma, Astrid;
    • Schouten, Philip C.;
    • Chin, Suet-Feung;
    • Pereira, Bernard;
    • Goldgraben, Mae A.;
    • Bismeijer, Tycho;
    • Kluin, Roelof J.C.;
    • Muris, Jettie J.F.;
    • Jirström, Karin;
    • Kerkhoven, Ron M.;
    • Wessels, Lodewyk;
    • Caldas, Carlos;
    • Bernards, René;
    • Simon, Iris M.;
    • Linn, Sabine
    Publication type:
    Article
    3

    Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease.

    Published in:
    Molecular Oncology, 2015, v. 9, n. 6, p. 1218, doi. 10.1016/j.molonc.2015.02.006
    By:
    • Jansen, Maurice P.H.M.;
    • Sas, Leen;
    • Sieuwerts, Anieta M.;
    • Van Cauwenberghe, Caroline;
    • Ramirez-Ardila, Diana;
    • Look, Maxime;
    • Ruigrok-Ritstier, Kirsten;
    • Finetti, Pascal;
    • Bertucci, François;
    • Timmermans, Mieke M.;
    • van Deurzen, Carolien H.M.;
    • Martens, John W.M.;
    • Simon, Iris;
    • Roepman, Paul;
    • Linn, Sabine C.;
    • van Dam, Peter;
    • Kok, Marleen;
    • Lardon, Filip;
    • Vermeulen, Peter B.;
    • Foekens, John A.
    Publication type:
    Article
    4
    5
    6
    7

    Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition.

    Published in:
    International Journal of Cancer, 2014, v. 134, n. 3, p. 552, doi. 10.1002/ijc.28387
    By:
    • Roepman, Paul;
    • Schlicker, Andreas;
    • Tabernero, Josep;
    • Majewski, Ian;
    • Tian, Sun;
    • Moreno, Victor;
    • Snel, Mireille H;
    • Chresta, Christine M;
    • Rosenberg, Robert;
    • Nitsche, Ulrich;
    • Macarulla, Teresa;
    • Capella, Gabriel;
    • Salazar, Ramon;
    • Orphanides, George;
    • Wessels, Lodewyk FA;
    • Bernards, Rene;
    • Simon, Iris M
    Publication type:
    Article
    8
    9

    Exchange of cellular components between platelets and tumor cells: impact on tumor cells behavior.

    Published in:
    Theranostics, 2022, v. 12, n. 5, p. 2150, doi. 10.7150/thno.64252
    By:
    • Rodriguez-Martinez, Alba;
    • Simon-Saez, Iris;
    • Perales, Sonia;
    • Garrido-Navas, Carmen;
    • Russo, Alessandro;
    • de Miguel-Perez, Diego;
    • Puche-Sanz, Ignacio;
    • Alaminos, Clara;
    • Ceron, Jorge;
    • Lorente, Jose A.;
    • Molina, Maria Pilar;
    • Gonzalez, Coral;
    • Cristofanilli, Massimo;
    • Ortigosa-Palomo, Alba;
    • Real, Pedro J.;
    • Rolfo, Christian;
    • Serrano, Maria J.
    Publication type:
    Article
    10

    Reproducibility of mRNA-Based Testing of ESR1 , PGR , ERBB2 , and MKI67 Expression in Invasive Breast Cancer—A Europe-Wide External Quality Assessment.

    Published in:
    Cancers, 2021, v. 13, n. 18, p. 4718, doi. 10.3390/cancers13184718
    By:
    • Erber, Ramona;
    • Hartmann, Arndt;
    • Fasching, Peter Andreas;
    • Ruebner, Matthias;
    • Stöhr, Robert;
    • Beckmann, Matthias Wilhelm;
    • Zentgraf, Miriam;
    • Popp, Verena;
    • Weidler, Jodi;
    • Simon, Iris;
    • Becker, Steffi;
    • Huebner, Hanna;
    • Fischer, Josephine;
    • Guerini Rocco, Elena;
    • Viale, Giuseppe;
    • Cayre, Anne;
    • Penault-Llorca, Frederique;
    • Caniego Casas, Tamara;
    • Pérez-Miés, Belén;
    • Palacios, José
    Publication type:
    Article
    11

    Cross-Resistance to Abiraterone and Enzalutamide in Castration Resistance Prostate Cancer Cellular Models Is Mediated by AR Transcriptional Reactivation.

    Published in:
    Cancers, 2021, v. 13, n. 6, p. 1483, doi. 10.3390/cancers13061483
    By:
    • Simon, Iris;
    • Perales, Sonia;
    • Casado-Medina, Laura;
    • Rodríguez-Martínez, Alba;
    • Garrido-Navas, Maria del Carmen;
    • Puche-Sanz, Ignacio;
    • Diaz-Mochon, Juan J.;
    • Alaminos, Clara;
    • Lupiañez, Pablo;
    • Lorente, Jose A.;
    • Serrano, María J.;
    • Real, Pedro J.;
    • Mahadevan, Daruka
    Publication type:
    Article
    12
    13
    14

    The consensus molecular subtypes of colorectal cancer.

    Published in:
    Nature Medicine, 2015, v. 21, n. 11, p. 1350, doi. 10.1038/nm.3967
    By:
    • Guinney, Justin;
    • Dienstmann, Rodrigo;
    • Wang, Xin;
    • de Reyniès, Aurélien;
    • Schlicker, Andreas;
    • Soneson, Charlotte;
    • Marisa, Laetitia;
    • Roepman, Paul;
    • Nyamundanda, Gift;
    • Angelino, Paolo;
    • Bot, Brian M;
    • Morris, Jeffrey S;
    • Simon, Iris M;
    • Gerster, Sarah;
    • Fessler, Evelyn;
    • De Sousa E Melo, Felipe;
    • Missiaglia, Edoardo;
    • Ramay, Hena;
    • Barras, David;
    • Homicsko, Krisztian
    Publication type:
    Article
    15
    16

    Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2017, v. 24, n. 13, p. 4051, doi. 10.1245/s10434-017-6054-5
    By:
    • Clarke, Callisia;
    • Lee, Michael;
    • Wei, Wei;
    • Manyam, Ganiraju;
    • Jiang, Zhi-Qin;
    • Lu, Yiling;
    • Morris, Jeffrey;
    • Broom, Bradley;
    • Menter, David;
    • Vilar-Sanchez, Eduardo;
    • Raghav, Kanwal;
    • Eng, Cathy;
    • Chang, George;
    • Simon, Iris;
    • Bernards, Rene;
    • Overman, Michael;
    • Mills, Gordon;
    • Maru, Dipen;
    • Kopetz, Scott
    Publication type:
    Article
    17
    18
    19
    20

    The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting.

    Published in:
    2017
    By:
    • Severson, Tesa M.;
    • Wolf, Denise M.;
    • Yau, Christina;
    • Peeters, Justine;
    • Wehkam, Diederik;
    • Schouten, Philip C.;
    • Chin, Suet-Feung;
    • Majewski, Ian J.;
    • Michaut, Magali;
    • Bosma, Astrid;
    • Pereira, Bernard;
    • Bismeijer, Tycho;
    • Wessels, Lodewyk;
    • Caldas, Carlos;
    • Bernards, René;
    • Simon, Iris M.;
    • Glas, Annuska M.;
    • Linn, Sabine;
    • van't Veer, Laura
    Publication type:
    journal article
    21